Related Experiment Video
Updated: Jun 12, 2025

08:36
In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
Published on: June 23, 2022
1.6K
Pre-metastatic niche: formation, characteristics and therapeutic implication
Yuhang Wang1, Jiachi Jia2, Fuqi Wang1
1Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, 1 East Jianshe Road, Zhengzhou, 450000, China.
Signal Transduction and Targeted Therapy
|September 24, 2024
Summary
Understanding the pre-metastatic niche, crucial for cancer spread, involves tumor factors, immune cells, and molecular changes. Targeting these elements offers new therapeutic strategies against distant metastasis.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Distant metastasis is a major cause of cancer mortality and poor surgical outcomes.
- Pre-metastatic niche formation is a critical early step preceding organ-specific metastasis.
- Understanding the pre-metastatic niche is key to developing effective anti-cancer therapies.
Purpose of the Study:
- To review the intricate landscape of the pre-metastatic niche.
- To elucidate the roles of cellular and molecular factors in its formation.
- To highlight therapeutic strategies targeting the pre-metastatic niche.
Main Methods:
- Comprehensive literature review on pre-metastatic niche formation.
- Analysis of tumor-derived factors, extracellular vesicles, and circulating tumor cells.
- Examination of cellular components (macrophages, neutrophils, immune cells) and molecular factors.
- Discussion of temporal mechanisms including EMT, immunosuppression, ECM remodeling, metabolic reprogramming, and angiogenesis.
- Elucidation of pre-metastatic niche characteristics in various organs (lymph nodes, lungs, liver, brain, bones).
Main Results:
- Pre-metastatic niche formation is orchestrated by tumor-derived factors, extracellular vesicles, and circulating tumor cells.
- Cellular players like macrophages, neutrophils, and immune cells significantly influence niche development.
- Molecular mechanisms such as epithelial-mesenchymal transition, immunosuppression, and angiogenesis are vital for niche establishment.
- The pre-metastatic niche exhibits distinct characteristics across different metastatic organ sites.
- Targeting cellular/molecular components and signaling pathways (TGF-β, VEGF, MET) shows therapeutic potential.
Conclusions:
- The pre-metastatic niche is a complex, dynamic microenvironment essential for cancer metastasis.
- Targeting the pre-metastatic niche offers a promising strategy to prevent or treat distant metastasis.
- Further research into pre-metastatic niche modulation can lead to novel therapeutic interventions.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

